“the actual submission is likely to be early 2024, after the adult trial commences.but if the FDA suggest that an AA submission would be a viable option, then that will bring forward potential approval by a fair bit as the AA review itself is unlikely to take very long with the manufacturing inspection already given the green tick. We will know shortly as @ddwn suggests, but clearly this possibility is not factored into the current share price and presents an opportunity for those who think it could come to fruition.” —> This was @stockrock ‘s reply to @07Gerard on 10 Aug.
If you are interested, I think @stockrock gave some background to the thinking in his reply - you can do an advanced search for his earlier post on the same day.
I wonder if anyone would be asking this process question at the upcoming results CC - seems to me to be highly relevant, @LearningEachDay, @ddwn, @Phaedrus - any thoughts?
- Forums
- ASX - By Stock
- MSB
- 2023 Next Steps
2023 Next Steps, page-86
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9590 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 3132 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9590 | 1.100 |
2 | 93370 | 1.095 |
11 | 125988 | 1.090 |
10 | 176709 | 1.085 |
17 | 270914 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 3132 | 1 |
1.115 | 50984 | 2 |
1.120 | 48985 | 5 |
1.125 | 78774 | 8 |
1.130 | 65843 | 1 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |